Raymond J. March
Raymond March is a faculty fellow at the NDSU Center for the Study of Public Choice and Private Enterprise (PCPE) an assistant professor in the NDSU Department of Agribusiness and Applied Economics, a fellow with the AIER Public Choice and Public Policy Project, and a contributor to Young Voices. His research has appeared in the Southern Economic Journal, Public Choice, Journal of Institutional Economics, and Research Policy. He has published articles in National Interest, Washington Times, Washington Examiner, The Hill, RealClearHealth, and elsewhere.
Raymond is a research fellow at the Independent Institute and the director of FDAReview.org, an educational research and communications project on the U.S. Food and Drug Administration (FDA).
-
•
Are EUAs Deregulation or Regulatory Capture?
“As the pandemic ends, there are plenty of frustrating examples of what went wrong. Let’s hope deregulation is remembered as an example of what went right.” ~ Raymond J. March
-
•
Did We Need Operation Warp Speed?
“OWS’s efforts to develop Covid-19 vaccines are often considered the crowning achievement of what went right. Unfortunately, I fear its benefits are exaggerated, and its costs are just beginning.” ~ Raymond J. March
-
•
Vaccine Cronyism
“As revealed through various documents well after OWS, we know the agreements limit vaccine developers not selected for OWS from expedited clinical trials and a transparent process for authorization.” ~ Raymond J. March
-
•
FDA Continues to Meddle With Covid-19 Treatments
“When the FDA and other agencies curtail private efforts to battle Covid-19, including limiting the use of existing and established treatments, we place our trust in less capable hands.” ~ Raymond J. March
-
•
Covid-19’s Ratchet Effect is Becoming Endemic
“Crises end, but newly designated powers and increased budgets governments receive throughout seldom end with them. Instead, government power exhibits a ratchet effect, never diminishing to pre-crisis levels.” ~ Raymond J. March
-
•
New Covid Variant – Same Government Blunders
“We know that mistakes in allocating medical goods to treat patients only make a challenging situation worse. The government has made many of these mistakes, and it doesn’t seem to be learning from them.” ~ Raymond J. March
-
•
The FDA is Back and Coming after Smart Socks
“Considering the FDA regulates nearly 40 percent of all consumer products, its recent actions are a strong cause for concern. As a health economist, I’ll be monitoring the situation closely.” ~ Raymond J. March
-
•
Gain of Function Controversy Demands Greater Scrutiny for Government-Funded Science
“Not every failure of government-funded science is as pervasive as the high-carb diet, as ghastly as the lobotomy, or as controversial as gain of function experiments. But the risk remains as long as the government remains a major funding source for research.” ~ Raymond J. March
-
•
Fumento Misdiagnoses Remdesivir
“Remdesivir gives a story of the triumph of innovation during a difficult period. The lesson we should take away is not ‘Do something, anything,’ it is to get government out of the way so we can find solutions.” ~ Raymond J. March
-
•
A Faster Drug Approval Process May Be Coming Soon!
“Recent history is on the side of less oversight and more patient access. Giving less power to government agencies to decide which drugs are safe and effective and under what circumstances provides more freedom for doctors and drug producers to help patients. It’s a literal life-or-death cause worth fighting for.” ~ Raymond J. March
-
•
Are EUAs Deregulation or Regulatory Capture?
“As the pandemic ends, there are plenty of frustrating examples of what went wrong. Let’s hope deregulation is remembered as an example of what went right.” ~ Raymond J. March
-
•
Did We Need Operation Warp Speed?
“OWS’s efforts to develop Covid-19 vaccines are often considered the crowning achievement of what went right. Unfortunately, I fear its benefits are exaggerated, and its costs are just beginning.” ~ Raymond J. March
-
•
Vaccine Cronyism
“As revealed through various documents well after OWS, we know the agreements limit vaccine developers not selected for OWS from expedited clinical trials and a transparent process for authorization.” ~ Raymond J. March
-
•
FDA Continues to Meddle With Covid-19 Treatments
“When the FDA and other agencies curtail private efforts to battle Covid-19, including limiting the use of existing and established treatments, we place our trust in less capable hands.” ~ Raymond J. March
-
•
Covid-19’s Ratchet Effect is Becoming Endemic
“Crises end, but newly designated powers and increased budgets governments receive throughout seldom end with them. Instead, government power exhibits a ratchet effect, never diminishing to pre-crisis levels.” ~ Raymond J. March
-
•
New Covid Variant – Same Government Blunders
“We know that mistakes in allocating medical goods to treat patients only make a challenging situation worse. The government has made many of these mistakes, and it doesn’t seem to be learning from them.” ~ Raymond J. March
-
•
The FDA is Back and Coming after Smart Socks
“Considering the FDA regulates nearly 40 percent of all consumer products, its recent actions are a strong cause for concern. As a health economist, I’ll be monitoring the situation closely.” ~ Raymond J. March
-
•
Gain of Function Controversy Demands Greater Scrutiny for Government-Funded Science
“Not every failure of government-funded science is as pervasive as the high-carb diet, as ghastly as the lobotomy, or as controversial as gain of function experiments. But the risk remains as long as the government remains a major funding source for research.” ~ Raymond J. March
-
•
Fumento Misdiagnoses Remdesivir
“Remdesivir gives a story of the triumph of innovation during a difficult period. The lesson we should take away is not ‘Do something, anything,’ it is to get government out of the way so we can find solutions.” ~ Raymond J. March
-
•
A Faster Drug Approval Process May Be Coming Soon!
“Recent history is on the side of less oversight and more patient access. Giving less power to government agencies to decide which drugs are safe and effective and under what circumstances provides more freedom for doctors and drug producers to help patients. It’s a literal life-or-death cause worth fighting for.” ~ Raymond J. March